|
CCNB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16979981257259E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.401100E-04 |
| Normal-vs-Stage2 |
9.066400E-02 |
| Normal-vs-Stage3 |
1.362510E-04 |
| Normal-vs-Stage4 |
4.116300E-03 |
| Stage1-vs-Stage2 |
5.362600E-01 |
| Stage1-vs-Stage3 |
1.275800E-03 |
| Stage1-vs-Stage4 |
2.080400E-03 |
| Stage2-vs-Stage3 |
9.398000E-03 |
| Stage2-vs-Stage4 |
6.710100E-02 |
| Stage3-vs-Stage4 |
5.183000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90869999594901E-08 |
| Normal-vs-AfricanAmerican |
5.766400E-04 |
| Normal-vs-Asian |
1.316400E-01 |
| Caucasian-vs-AfricanAmerican |
7.832200E-01 |
| Caucasian-vs-Asian |
2.657400E-01 |
| AfricanAmerican-vs-Asian |
2.866200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.6398000004605E-07 |
| Normal-vs-Female |
6.48809999947986E-07 |
| Male-vs-Female |
1.295600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.829900E-04 |
| Normal-vs-Extreme_Weight |
4.002300E-03 |
| Normal-vs-Obese |
1.211550E-04 |
| Normal-vs-Extreme_Obese |
6.263600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.634100E-02 |
| Normal_Weight-vs-Obese |
8.018000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.576740E-03 |
| Extreme_Weight-vs-Obese |
3.820100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.461600E-02 |
| Obese-vs-Extreme_Obese |
7.835600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.122400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.05969999997235E-07 |
| Normal-vs-Age(61-80Yrs) |
4.043700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.824470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.544970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.962400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.333700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.338000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.930200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.442460E-03 |
| Normal-VS-Type2 PRCC |
2.29459999999682E-05 |
| Normal-VS-KIRP CIMP |
7.360800E-04 |
| Normal-VS-Unclassified PRCC |
4.677000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.682300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.462990E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.131500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.298100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.849200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.171800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.518000E-03 |
| Normal-vs-N1 |
1.76551999999663E-05 |
| Normal-vs-N2 |
1.627760E-01 |
| N0-vs-N1 |
5.220800E-04 |
| N0-vs-N2 |
6.843600E-02 |
| N1-vs-N2 |
6.125600E-01 |
|
|
